Mosaic Biosciences
PrivateLast Round
Series B
Jun 14, 2022
Total Funding Raised
$13.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mosaic Biosciences operates in Healthcare & Life Sciences and is based in Boulder, Colorado. Its latest recorded funding round was a Series B round in June 2022.
Mosaic Biosciences is a biopharmaceutical company that provides research programs to advance clinical candidates.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mosaic Biosciences Comparables
Compare Mosaic Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FairJourney Biologics | 85% | |
| AlivaMab Biologics | 84% | |
| Creative Biolabs | 81% |
For institutional investors. Book with your work email.
Mosaic Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 14, 2022 | ||||
| Series A Extension | Feb 1, 2014 | ||||
| Series A | Jul 20, 2011 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mosaic Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| High Country Venture | Series A Extension, Series A |
| HealthCare Ventures | Series A Extension |
| Telegraph Hill Partners | Series B |
| Morgenthaler Ventures | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 29, 60% of headcount.
- Jul 13, 2026
Open roles increased from 0 to 8, representing 17% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_revenueSep 18, 2026
Mosaic Biosciences, Inc. reports $12B in total company revenue for 2025, compared with US$68 million in global sales.
- launchesSep 8, 2026
Mosaic Biosciences, Inc. launches Tessaic Nano in Colorado on Sep 8th '26, giving clients a fully human synthetic in vitro VHH library designed to accelerate nanobody discovery across therapeutic, diagnostic, and research applications.
- partners_withAug 5, 2026
Mosaic Biosciences, Inc. and Uniquity Bio, Inc. partner in biologics development to advance high-quality biologic candidates by combining biologics discovery expertise, scientific rigor, and a clinical-stage pipeline on Aug 5th '26.
For institutional investors. Book with your work email.
Mosaic Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mosaic Biosciences's valuation, stock price, and market status.
Is Mosaic Biosciences a public or private company?
Mosaic Biosciences is a private company.
What is the current stock price of Mosaic Biosciences?
Mosaic Biosciences is a private company, so its shares have no public market price. Caplight tracks Mosaic Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mosaic Biosciences worth (valuation)?
Valuation information for Mosaic Biosciences is not publicly available.
Can I buy Mosaic Biosciences stock?
Mosaic Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mosaic Biosciences's last funding round?
Mosaic Biosciences's most recent funding round was Series B on June 14, 2022.
Who are the main investors in Mosaic Biosciences?
Key investors in Mosaic Biosciences include Telegraph Hill Partners.
Will Mosaic Biosciences IPO soon?
No public IPO plans have been announced for Mosaic Biosciences.
How can I track Mosaic Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Mosaic Biosciences's shares on secondary markets.